These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1825127)

  • 21. Natriuretic and hypotensive effects of alpha-human atrial natriuretic polypeptide in anaesthetized DOCA-salt hypertensive rats.
    Kondo K; Kida O; Kangawa K; Matsuo H; Tanaka K
    Clin Exp Pharmacol Physiol; 1986 Feb; 13(2):97-101. PubMed ID: 2940041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of brain natriuretic peptide in rats.
    Hashimoto Y; Nakao K; Hama N; Mukoyama M; Imura H; Yasuhara M; Hori R
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1650-2. PubMed ID: 1394689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific binding of atrial natriuretic factor to renal glomeruli in Doca- and Doca-salt-treated rats correlation with atrial and plasma levels.
    Gauquelin G; Schiffrin EL; Cantin M; Garcia R
    Biochem Biophys Res Commun; 1987 May; 145(1):522-31. PubMed ID: 3036134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natriuretic and hypotensive effects of brain natriuretic peptide in anaesthetized DOCA-salt hypertensive rats.
    Kita T; Kida O; Kato J; Nakamura S; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K
    Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):185-90. PubMed ID: 2721031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased substance P content in nerve fibers associated with mesenteric veins from deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Galligan JJ; Miller SB; Katki K; Supowit S; DiPette D; Fink GD
    Regul Pept; 2006 Jan; 133(1-3):97-104. PubMed ID: 16297989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between cardiac hypertrophy and plasma levels of atrial natriuretic factor in non-spontaneous models of hypertension in the rat.
    Garcia R; Thibault G; Cantin M
    Biochem Biophys Res Commun; 1987 May; 145(1):532-41. PubMed ID: 2954551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diuretic chlorthalidone normalizes baroreceptor and Bezold-Jarisch reflexes in DOCA-salt hypertensive rats.
    Bissoli NS; Cicilini MA; Vasquez EC; Cabral AM
    Pharmacol Res; 2000 Apr; 41(4):483-91. PubMed ID: 10704274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infusion of atrial natriuretic hormone in DOCA/salt and spontaneously hypertensive rats.
    Fujimura A; Kyker KD; Kem DC
    Acta Endocrinol (Copenh); 1989 Oct; 121(4):567-72. PubMed ID: 2529729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological effects of rat iso-atrial natriuretic peptide and brain natriuretic peptide are indistinguishable from each other.
    Wigle DA; Bennett BM; Jennings DB; Sarda IR; Flynn TG; Pang SC
    Can J Physiol Pharmacol; 1992 Nov; 70(11):1525-8. PubMed ID: 1338375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressive effect of sulfate on the development of hypertension in DOCA-salt hypertensive rats.
    Kubota Y; Sano H; Kawahara J; Hattori K; Miki T; Suzuki H; Fukuzaki H
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):169-72. PubMed ID: 2021448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
    Rothermund L; Vetter R; Dieterich M; Kossmehl P; Gögebakan O; Yagil C; Yagil Y; Kreutz R
    Circulation; 2002 Oct; 106(18):2305-8. PubMed ID: 12403658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
    Ammarguellat F; Larouche I; Schiffrin EL
    Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma atrial natriuretic peptide in DOCA-NaCl-treated rats.
    Tikkanen T; Tikkanen I; Fyhrquist F
    Acta Physiol Scand; 1987 Feb; 129(2):151-5. PubMed ID: 2953170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoactive iso-ANP/BNP in plasma, tissues and atrial granules of the rat.
    Hira GK; Sarda IR; Wong ST; Pang SC; Flynn TG
    Regul Pept; 1993 Mar; 44(1):1-9. PubMed ID: 8484014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
    Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.